NIT
ALLO icon

NumerixS Investment Technologies’s Allogene Therapeutics ALLO Stock Holding History

NumerixS Investment Technologies’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,058
Closed -$88K – 41
2020
Q2 		$88K Buy
2,058
+258
+14% +$9.33K 0.02% 620
2020
Q1 		$35K Sell
1,800
-3,108
-63% -$74K 0.02% 700
2019
Q4 		$128K Buy
4,908
+1,708
+53% +$47K 0.03% 612
2019
Q3 		$87K Sell
3,200
-1,000
-24% -$28.5K 0.02% 588
2019
Q2 		$113K Sell
4,200
-800
-16% -$22.3K 0.03% 565
2019
Q1 		$136K Buy
+5,000
New +$145K 0.02% 778

Other funds holding ALLO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

NumerixS Investment Technologies's ALLO Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Allogene Therapeutics (ALLO) in Q3 2020, closing a stake of 2,058 shares — an estimated $88K sold.

NumerixS Investment Technologies first reported a position in ALLO in Q1 2019 and held it in 6 quarters. The position peaked at $136K in Q1 2019. 162 funds tracked by Wall St. Rank hold ALLO as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Allogene Therapeutics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,058 Allogene Therapeutics shares in Q3 2020, an estimated $88K.
  • NumerixS Investment Technologies first reported a position in Allogene Therapeutics in Q1 2019 and held it in 6 quarters.
  • NumerixS Investment Technologies's Allogene Therapeutics position peaked at $136K in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.